Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ACADEMIA
ACADEMIA
- Oita University Completes Dosing of Replicon RNA Vaccine in PI, Eyes Global PII/III
January 19, 2022
- Kyoto Univ., Takeda Succeed in Treating Muscular Dystrophy in Model Mice Using Genome Editing
December 10, 2021
- With First Ophthalmologic Biosimilar Set to Debut, Specialist Says Close Attention Required for Unexpected Side Effects
December 9, 2021
- Swift Actions to Improve Diagnostic System, Control Costs Required to Prep for Potential Aducanumab Debut: JSDR Confab
November 30, 2021
- Anti-CGRP Antibodies Cut Headaches in 70% of Patients, but Cost Will Be Major Obstacle: Specialist
October 21, 2021
- Japan Headache Society Clarifies Patients Suitable for CGRP Migraine Meds, No Drug Selection Criteria Given for Now
October 21, 2021
- For Hypertension, Entresto Expected as or More Effective than ARBs/ACE Inhibitors: Professor
October 21, 2021
- NCC Kicks Off Asia’s Clinical Data Sharing Project, Starting with Bowel Cancer
October 4, 2021
- NCC to Launch Search Portal for Cancer Genomic Data on Oct. 4; Support Drug Makers’ R&D
October 1, 2021
- Forxiga Could Treat 3 Million CKD Patients in Japan, Potentially Be 1st Choice Drug: Professor
October 1, 2021
- Evrysdi Offers New Option for SMA Patients with Scoliosis: KOL
September 29, 2021
- Use Oral Dexamethasone for COVID-19 Patients Requiring Oxygen: Scientific Societies
September 10, 2021
- Oita University to Begin PI Study for Replicon RNA Vaccine in October
September 10, 2021
- Systemic Symptoms Unlikely to Occur from Contaminated Moderna Jabs: Japan Vaccinology Society
September 9, 2021
- Darzquro Expected to Treat 900 AL Amyloidosis Patients in Japan Annually: Specialist
September 6, 2021
- 1st COVID-19 Delta Variant Mutation Found in Japan: TMDU
August 31, 2021
- TMDU, Takeda Running Joint Research on Heteroduplex Oligonucleotide for Neuro Diseases
August 24, 2021
- Evrysdi Debut Expands SMA Treatment Options, Improved Use Expected for All 3 Drugs: Professor
August 16, 2021
- Osteoporosis Society Greatly Alarmed by Vitamin D3 Analog Shortages, Might Take Further Measures
July 29, 2021
- Scientific Societies Propose Measures for Osteoporosis Treatment amid Shortages of Vitamin D Analogs
July 21, 2021
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…